DLJ and Leggat McCall Open Somerville Life Sciences Facility

Published 5/23/2022

101 South Street - DLJ Real Estate Capital Partners and Leggat McCall Properties

^{Courtesy of SGA.}

101 South Street - DLJ Real Estate Capital Partners and Leggat McCall Properties

^{Courtesy of Unmarked Studios.}

101 South Street - DLJ Real Estate Capital Partners and Leggat McCall Properties

^{Courtesy of SGA.}

101 South Street - DLJ Real Estate Capital Partners and Leggat McCall Properties

^{Courtesy of SGA.}

101 South Street - DLJ Real Estate Capital Partners and Leggat McCall Properties

^{Courtesy of SGA.}

Somerville, Mass.

DLJ Real Estate Capital Partners and Leggat McCall Properties opened a 289,000-sf life sciences facility in Somerville in May of 2022. Designed by SGA and Hashim Sarkis Studios, the nine-story structure provides Class-A lab and office environments supported by robust mechanical and electrical infrastructure. Offering flexible floorplates with column-free spans of 35,000 sf, the sustainable development is targeting LEED Gold and WiredScore Platinum certifications. Amenities include a shared conference venue, a fitness center, and four levels of below-grade parking. The building was leased prior to completion by Flagship Pioneering, Tessera Therapeutics, Laronde, Cellarity, and Generate Biomedicines, with Cushman & Wakefield acting as leasing agent. Shawmut Design & Construction began work on the project in July of 2019.

Located in the Boynton Yards mixed-use district, the facility is the first of four research buildings that will complement the seven-acre site's residential, commercial, and community spaces.